nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—NTRK1—midbrain—nicotine dependence	0.023	0.0647	CbGeAlD
Regorafenib—DDR2—cardiovascular system—nicotine dependence	0.0219	0.0616	CbGeAlD
Regorafenib—Cyst—Varenicline—nicotine dependence	0.0171	0.0713	CcSEcCtD
Regorafenib—Dysphonia—Varenicline—nicotine dependence	0.0139	0.0579	CcSEcCtD
Regorafenib—Endocrine disorder—Varenicline—nicotine dependence	0.0138	0.0575	CcSEcCtD
Regorafenib—FLT4—cardiovascular system—nicotine dependence	0.0133	0.0375	CbGeAlD
Regorafenib—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0127	0.0527	CcSEcCtD
Regorafenib—BRAF—midbrain—nicotine dependence	0.0121	0.034	CbGeAlD
Regorafenib—FGFR2—cardiovascular system—nicotine dependence	0.0112	0.0315	CbGeAlD
Regorafenib—EPHA2—cardiovascular system—nicotine dependence	0.011	0.0309	CbGeAlD
Regorafenib—DDR2—brain—nicotine dependence	0.0107	0.0302	CbGeAlD
Regorafenib—TEK—cardiovascular system—nicotine dependence	0.0107	0.0302	CbGeAlD
Regorafenib—FLT1—cardiovascular system—nicotine dependence	0.0104	0.0292	CbGeAlD
Regorafenib—RAF1—cardiovascular system—nicotine dependence	0.0103	0.029	CbGeAlD
Regorafenib—FGFR1—midbrain—nicotine dependence	0.0103	0.0289	CbGeAlD
Regorafenib—MAPK11—brain—nicotine dependence	0.0102	0.0286	CbGeAlD
Regorafenib—PDGFRA—cardiovascular system—nicotine dependence	0.0097	0.0273	CbGeAlD
Regorafenib—RET—midbrain—nicotine dependence	0.00918	0.0259	CbGeAlD
Regorafenib—KDR—cardiovascular system—nicotine dependence	0.00875	0.0247	CbGeAlD
Regorafenib—TEK—midbrain—nicotine dependence	0.00836	0.0236	CbGeAlD
Regorafenib—FLT1—midbrain—nicotine dependence	0.00809	0.0228	CbGeAlD
Regorafenib—RAF1—midbrain—nicotine dependence	0.00804	0.0226	CbGeAlD
Regorafenib—KIT—cardiovascular system—nicotine dependence	0.00776	0.0218	CbGeAlD
Regorafenib—Dry skin—Varenicline—nicotine dependence	0.00762	0.0317	CcSEcCtD
Regorafenib—BRAF—brain—nicotine dependence	0.00758	0.0214	CbGeAlD
Regorafenib—PDGFRB—cardiovascular system—nicotine dependence	0.00758	0.0213	CbGeAlD
Regorafenib—Hypokalaemia—Varenicline—nicotine dependence	0.00757	0.0315	CcSEcCtD
Regorafenib—EPHX2—brain—nicotine dependence	0.00725	0.0204	CbGeAlD
Regorafenib—KDR—midbrain—nicotine dependence	0.00684	0.0193	CbGeAlD
Regorafenib—ABL1—cardiovascular system—nicotine dependence	0.00675	0.019	CbGeAlD
Regorafenib—FLT4—brain—nicotine dependence	0.00654	0.0184	CbGeAlD
Regorafenib—FGFR1—brain—nicotine dependence	0.00645	0.0182	CbGeAlD
Regorafenib—Infestation—Varenicline—nicotine dependence	0.00641	0.0267	CcSEcCtD
Regorafenib—Infestation NOS—Varenicline—nicotine dependence	0.00641	0.0267	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00635	0.0264	CcSEcCtD
Regorafenib—Acute coronary syndrome—Varenicline—nicotine dependence	0.00632	0.0263	CcSEcCtD
Regorafenib—Myocardial infarction—Varenicline—nicotine dependence	0.00628	0.0261	CcSEcCtD
Regorafenib—Stomatitis—Varenicline—nicotine dependence	0.00625	0.026	CcSEcCtD
Regorafenib—Hepatobiliary disease—Varenicline—nicotine dependence	0.00606	0.0252	CcSEcCtD
Regorafenib—KIT—midbrain—nicotine dependence	0.00606	0.0171	CbGeAlD
Regorafenib—PDGFRB—midbrain—nicotine dependence	0.00592	0.0167	CbGeAlD
Regorafenib—RET—brain—nicotine dependence	0.00577	0.0163	CbGeAlD
Regorafenib—Urinary tract disorder—Varenicline—nicotine dependence	0.00568	0.0236	CcSEcCtD
Regorafenib—Connective tissue disorder—Varenicline—nicotine dependence	0.00565	0.0235	CcSEcCtD
Regorafenib—Urethral disorder—Varenicline—nicotine dependence	0.00564	0.0235	CcSEcCtD
Regorafenib—FGFR2—brain—nicotine dependence	0.00548	0.0154	CbGeAlD
Regorafenib—Erythema multiforme—Varenicline—nicotine dependence	0.00544	0.0226	CcSEcCtD
Regorafenib—EPHA2—brain—nicotine dependence	0.00539	0.0152	CbGeAlD
Regorafenib—Cardiac disorder—Varenicline—nicotine dependence	0.00534	0.0222	CcSEcCtD
Regorafenib—ABL1—midbrain—nicotine dependence	0.00527	0.0149	CbGeAlD
Regorafenib—TEK—brain—nicotine dependence	0.00526	0.0148	CbGeAlD
Regorafenib—Angiopathy—Varenicline—nicotine dependence	0.00522	0.0217	CcSEcCtD
Regorafenib—Mediastinal disorder—Varenicline—nicotine dependence	0.00518	0.0216	CcSEcCtD
Regorafenib—FLT1—brain—nicotine dependence	0.00508	0.0143	CbGeAlD
Regorafenib—RAF1—brain—nicotine dependence	0.00505	0.0142	CbGeAlD
Regorafenib—Malnutrition—Varenicline—nicotine dependence	0.00501	0.0208	CcSEcCtD
Regorafenib—PDGFRA—brain—nicotine dependence	0.00476	0.0134	CbGeAlD
Regorafenib—Tremor—Varenicline—nicotine dependence	0.00469	0.0195	CcSEcCtD
Regorafenib—Anaemia—Varenicline—nicotine dependence	0.00463	0.0192	CcSEcCtD
Regorafenib—Hypertension—Varenicline—nicotine dependence	0.00432	0.018	CcSEcCtD
Regorafenib—KDR—brain—nicotine dependence	0.0043	0.0121	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00423	0.0176	CcSEcCtD
Regorafenib—Dry mouth—Varenicline—nicotine dependence	0.00417	0.0173	CcSEcCtD
Regorafenib—Infection—Varenicline—nicotine dependence	0.00406	0.0169	CcSEcCtD
Regorafenib—Nervous system disorder—Varenicline—nicotine dependence	0.00401	0.0167	CcSEcCtD
Regorafenib—Thrombocytopenia—Varenicline—nicotine dependence	0.004	0.0166	CcSEcCtD
Regorafenib—Skin disorder—Varenicline—nicotine dependence	0.00397	0.0165	CcSEcCtD
Regorafenib—CYP2B6—cardiovascular system—nicotine dependence	0.00393	0.0111	CbGeAlD
Regorafenib—CYP2C9—cardiovascular system—nicotine dependence	0.00389	0.011	CbGeAlD
Regorafenib—KIT—brain—nicotine dependence	0.00381	0.0107	CbGeAlD
Regorafenib—PDGFRB—brain—nicotine dependence	0.00372	0.0105	CbGeAlD
Regorafenib—Decreased appetite—Varenicline—nicotine dependence	0.00355	0.0148	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00353	0.0147	CcSEcCtD
Regorafenib—Fatigue—Varenicline—nicotine dependence	0.00352	0.0147	CcSEcCtD
Regorafenib—Pain—Varenicline—nicotine dependence	0.00349	0.0145	CcSEcCtD
Regorafenib—Gastrointestinal pain—Varenicline—nicotine dependence	0.00334	0.0139	CcSEcCtD
Regorafenib—ABCG2—midbrain—nicotine dependence	0.00333	0.00937	CbGeAlD
Regorafenib—ABL1—brain—nicotine dependence	0.00331	0.00933	CbGeAlD
Regorafenib—Body temperature increased—Varenicline—nicotine dependence	0.00323	0.0134	CcSEcCtD
Regorafenib—Abdominal pain—Varenicline—nicotine dependence	0.00323	0.0134	CcSEcCtD
Regorafenib—Asthenia—Varenicline—nicotine dependence	0.00293	0.0122	CcSEcCtD
Regorafenib—Diarrhoea—Varenicline—nicotine dependence	0.0028	0.0116	CcSEcCtD
Regorafenib—Vomiting—Varenicline—nicotine dependence	0.0026	0.0108	CcSEcCtD
Regorafenib—Rash—Varenicline—nicotine dependence	0.00258	0.0107	CcSEcCtD
Regorafenib—Dermatitis—Varenicline—nicotine dependence	0.00257	0.0107	CcSEcCtD
Regorafenib—Headache—Varenicline—nicotine dependence	0.00256	0.0106	CcSEcCtD
Regorafenib—Nausea—Varenicline—nicotine dependence	0.00243	0.0101	CcSEcCtD
Regorafenib—NTRK1—Signaling by NGF—FGD1—nicotine dependence	0.00241	0.00595	CbGpPWpGaD
Regorafenib—ABL1—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.0024	0.00593	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—CHRNB3—nicotine dependence	0.00237	0.00586	CbGpPWpGaD
Regorafenib—BRAF—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00234	0.00578	CbGpPWpGaD
Regorafenib—RAF1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00226	0.00558	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—CHRNA6—nicotine dependence	0.00225	0.00555	CbGpPWpGaD
Regorafenib—CYP2C8—brain—nicotine dependence	0.00215	0.00605	CbGeAlD
Regorafenib—RAF1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00214	0.00529	CbGpPWpGaD
Regorafenib—BRAF—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00212	0.00524	CbGpPWpGaD
Regorafenib—ABCB1—cardiovascular system—nicotine dependence	0.0021	0.00591	CbGeAlD
Regorafenib—ABCG2—brain—nicotine dependence	0.00209	0.00589	CbGeAlD
Regorafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00208	0.00514	CbGpPWpGaD
Regorafenib—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00205	0.00507	CbGpPWpGaD
Regorafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00205	0.00506	CbGpPWpGaD
Regorafenib—BRAF—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00203	0.00502	CbGpPWpGaD
Regorafenib—BRAF—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00203	0.00502	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00203	0.00501	CbGpPWpGaD
Regorafenib—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00199	0.00492	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—FGD1—nicotine dependence	0.00196	0.00484	CbGpPWpGaD
Regorafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00195	0.00482	CbGpPWpGaD
Regorafenib—BRAF—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00195	0.00482	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—FGD1—nicotine dependence	0.00194	0.00479	CbGpPWpGaD
Regorafenib—CYP2B6—brain—nicotine dependence	0.00193	0.00543	CbGeAlD
Regorafenib—BRAF—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00189	0.00467	CbGpPWpGaD
Regorafenib—FGFR2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00188	0.00466	CbGpPWpGaD
Regorafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00187	0.00462	CbGpPWpGaD
Regorafenib—RAF1—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00186	0.0046	CbGpPWpGaD
Regorafenib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00186	0.00459	CbGpPWpGaD
Regorafenib—RAF1—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00183	0.00453	CbGpPWpGaD
Regorafenib—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00183	0.00453	CbGpPWpGaD
Regorafenib—RAF1—TCR Signaling Pathway—OPRM1—nicotine dependence	0.00182	0.00449	CbGpPWpGaD
Regorafenib—PDGFRB—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00182	0.00449	CbGpPWpGaD
Regorafenib—FGFR2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00181	0.00446	CbGpPWpGaD
Regorafenib—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0018	0.00446	CbGpPWpGaD
Regorafenib—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0018	0.00446	CbGpPWpGaD
Regorafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.0018	0.00446	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—FGD1—nicotine dependence	0.0018	0.00444	CbGpPWpGaD
Regorafenib—ABL1—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00177	0.00437	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—FGD1—nicotine dependence	0.00176	0.00436	CbGpPWpGaD
Regorafenib—RAF1—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00176	0.00434	CbGpPWpGaD
Regorafenib—FGFR1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00176	0.00434	CbGpPWpGaD
Regorafenib—PDGFRA—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00175	0.00433	CbGpPWpGaD
Regorafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00174	0.0043	CbGpPWpGaD
Regorafenib—RAF1—Ion channel transport—GABRA4—nicotine dependence	0.00174	0.00429	CbGpPWpGaD
Regorafenib—RAF1—Signaling by VEGF—WASF2—nicotine dependence	0.00173	0.00428	CbGpPWpGaD
Regorafenib—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.0017	0.0042	CbGpPWpGaD
Regorafenib—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.0017	0.0042	CbGpPWpGaD
Regorafenib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00169	0.00418	CbGpPWpGaD
Regorafenib—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00169	0.00417	CbGpPWpGaD
Regorafenib—FGFR1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00168	0.00416	CbGpPWpGaD
Regorafenib—PDGFRA—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00168	0.00415	CbGpPWpGaD
Regorafenib—NTRK1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00168	0.00415	CbGpPWpGaD
Regorafenib—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00168	0.00415	CbGpPWpGaD
Regorafenib—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00168	0.00415	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—FGD1—nicotine dependence	0.00167	0.00414	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—FGD1—nicotine dependence	0.00167	0.00413	CbGpPWpGaD
Regorafenib—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00167	0.00413	CbGpPWpGaD
Regorafenib—RAF1—Signaling by VEGF—WASF1—nicotine dependence	0.00166	0.0041	CbGpPWpGaD
Regorafenib—ABCB1—midbrain—nicotine dependence	0.00164	0.00462	CbGeAlD
Regorafenib—RAF1—Neuronal System—CHRNB3—nicotine dependence	0.00164	0.00405	CbGpPWpGaD
Regorafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00164	0.00405	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—GABRA4—nicotine dependence	0.00162	0.00401	CbGpPWpGaD
Regorafenib—RAF1—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00162	0.004	CbGpPWpGaD
Regorafenib—PDGFRB—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00158	0.0039	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—CHRNB4—nicotine dependence	0.00156	0.00385	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—CHRNA6—nicotine dependence	0.00155	0.00384	CbGpPWpGaD
Regorafenib—BRAF—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00154	0.00381	CbGpPWpGaD
Regorafenib—PDGFRB—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00151	0.00374	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—FGD1—nicotine dependence	0.0015	0.00372	CbGpPWpGaD
Regorafenib—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0015	0.00372	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00147	0.00362	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—CHRNA5—nicotine dependence	0.00145	0.00358	CbGpPWpGaD
Regorafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00142	0.0035	CbGpPWpGaD
Regorafenib—RAF1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00141	0.00348	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00141	0.00347	CbGpPWpGaD
Regorafenib—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00137	0.00339	CbGpPWpGaD
Regorafenib—BRAF—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00136	0.00335	CbGpPWpGaD
Regorafenib—RAF1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00135	0.00333	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—FGD1—nicotine dependence	0.00134	0.00331	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00131	0.00323	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TAS2R16—nicotine dependence	0.00125	0.0031	CbGpPWpGaD
Regorafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00125	0.00308	CbGpPWpGaD
Regorafenib—NTRK1—Circadian rythm related genes—DRD2—nicotine dependence	0.00124	0.00307	CbGpPWpGaD
Regorafenib—BRAF—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00123	0.00304	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—CHRNA3—nicotine dependence	0.00118	0.00292	CbGpPWpGaD
Regorafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00113	0.0028	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—GABRA4—nicotine dependence	0.00112	0.00278	CbGpPWpGaD
Regorafenib—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00112	0.00277	CbGpPWpGaD
Regorafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00112	0.00276	CbGpPWpGaD
Regorafenib—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0011	0.00272	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—CHRNB4—nicotine dependence	0.00108	0.00266	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00107	0.00263	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00106	0.00261	CbGpPWpGaD
Regorafenib—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00104	0.00258	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—CHRNB2—nicotine dependence	0.00104	0.00257	CbGpPWpGaD
Regorafenib—ABCB1—brain—nicotine dependence	0.00103	0.0029	CbGeAlD
Regorafenib—RAF1—Neuronal System—CHRNA5—nicotine dependence	0.001	0.00247	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—FGD1—nicotine dependence	0.000985	0.00243	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—CYP2A7—nicotine dependence	0.000983	0.00243	CbGpPWpGaD
Regorafenib—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00095	0.00235	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—CHRNA4—nicotine dependence	0.000943	0.00233	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000938	0.00232	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TAS2R16—nicotine dependence	0.000936	0.00231	CbGpPWpGaD
Regorafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000905	0.00224	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000895	0.00221	CbGpPWpGaD
Regorafenib—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000883	0.00218	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—AKR1B10—nicotine dependence	0.00087	0.00215	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000852	0.00211	CbGpPWpGaD
Regorafenib—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000848	0.0021	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—CCAR1—nicotine dependence	0.000824	0.00204	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—CHRNA3—nicotine dependence	0.000816	0.00202	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000799	0.00198	CbGpPWpGaD
Regorafenib—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000788	0.00195	CbGpPWpGaD
Regorafenib—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000773	0.00191	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—FGD1—nicotine dependence	0.000735	0.00182	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000729	0.0018	CbGpPWpGaD
Regorafenib—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000719	0.00178	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—CHRNB2—nicotine dependence	0.000719	0.00178	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—WASF2—nicotine dependence	0.000695	0.00172	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—WASF1—nicotine dependence	0.000666	0.00165	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000659	0.00163	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—CHRNA4—nicotine dependence	0.000653	0.00161	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—AKR1B10—nicotine dependence	0.000649	0.0016	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—WASF2—nicotine dependence	0.000638	0.00158	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—WASF2—nicotine dependence	0.000626	0.00155	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TAS2R16—nicotine dependence	0.000623	0.00154	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000621	0.00154	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—WASF2—nicotine dependence	0.000613	0.00151	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—WASF1—nicotine dependence	0.000611	0.00151	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000604	0.00149	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—WASF1—nicotine dependence	0.0006	0.00148	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—WASF2—nicotine dependence	0.000594	0.00147	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—WASF2—nicotine dependence	0.000593	0.00147	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—WASF1—nicotine dependence	0.000587	0.00145	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—WASF1—nicotine dependence	0.00057	0.00141	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—WASF1—nicotine dependence	0.000568	0.0014	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TAS2R16—nicotine dependence	0.000536	0.00132	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—WASF2—nicotine dependence	0.000534	0.00132	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TAS2R16—nicotine dependence	0.000531	0.00131	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—OPRM1—nicotine dependence	0.000529	0.00131	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000527	0.0013	CbGpPWpGaD
Regorafenib—BRAF—Disease—AKR1B10—nicotine dependence	0.000525	0.0013	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—WASF2—nicotine dependence	0.00052	0.00129	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—FGD1—nicotine dependence	0.000517	0.00128	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—WASF1—nicotine dependence	0.000512	0.00127	CbGpPWpGaD
Regorafenib—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00051	0.00126	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—WASF1—nicotine dependence	0.000499	0.00123	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TAS2R16—nicotine dependence	0.000492	0.00122	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—FGD1—nicotine dependence	0.000489	0.00121	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—FGD1—nicotine dependence	0.000488	0.00121	CbGpPWpGaD
Regorafenib—FGFR2—Disease—AKR1B10—nicotine dependence	0.000487	0.0012	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TAS2R16—nicotine dependence	0.000483	0.00119	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000481	0.00119	CbGpPWpGaD
Regorafenib—KIT—Disease—AKR1B10—nicotine dependence	0.000478	0.00118	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—WASF2—nicotine dependence	0.000476	0.00118	CbGpPWpGaD
Regorafenib—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000474	0.00117	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TAS2R16—nicotine dependence	0.000458	0.00113	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TAS2R16—nicotine dependence	0.000457	0.00113	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—WASF2—nicotine dependence	0.000457	0.00113	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AKR1B10—nicotine dependence	0.000457	0.00113	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—WASF1—nicotine dependence	0.000456	0.00113	CbGpPWpGaD
Regorafenib—FGFR1—Disease—AKR1B10—nicotine dependence	0.000454	0.00112	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—AKR1B10—nicotine dependence	0.000452	0.00112	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—WASF1—nicotine dependence	0.000438	0.00108	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AKR1B10—nicotine dependence	0.000432	0.00107	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—FGD1—nicotine dependence	0.00042	0.00104	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—FGD1—nicotine dependence	0.000416	0.00103	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TAS2R16—nicotine dependence	0.000412	0.00102	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—AKR1B10—nicotine dependence	0.000408	0.00101	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—WASF2—nicotine dependence	0.000405	0.001	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—OPRM1—nicotine dependence	0.000395	0.000975	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—WASF1—nicotine dependence	0.000388	0.000959	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—FGD1—nicotine dependence	0.000386	0.000954	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—DRD2—nicotine dependence	0.000382	0.000945	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—FGD1—nicotine dependence	0.000379	0.000937	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—WASF2—nicotine dependence	0.000371	0.000918	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AKR1B10—nicotine dependence	0.000371	0.000918	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AKR1B10—nicotine dependence	0.000368	0.000909	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TAS2R16—nicotine dependence	0.000367	0.000907	CbGpPWpGaD
Regorafenib—KIT—Immune System—WASF2—nicotine dependence	0.000365	0.000902	CbGpPWpGaD
Regorafenib—RAF1—Disease—AKR1B10—nicotine dependence	0.000363	0.000898	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—FGD1—nicotine dependence	0.00036	0.000889	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—FGD1—nicotine dependence	0.000359	0.000887	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—WASF1—nicotine dependence	0.000356	0.00088	CbGpPWpGaD
Regorafenib—KIT—Immune System—WASF1—nicotine dependence	0.00035	0.000864	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—WASF2—nicotine dependence	0.000346	0.000856	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—WASF2—nicotine dependence	0.000345	0.000854	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AKR1B10—nicotine dependence	0.000341	0.000842	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AKR1B10—nicotine dependence	0.000335	0.000827	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—WASF1—nicotine dependence	0.000332	0.00082	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—WASF1—nicotine dependence	0.000331	0.000818	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—FGD1—nicotine dependence	0.000323	0.000799	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—WASF2—nicotine dependence	0.000322	0.000796	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AKR1B10—nicotine dependence	0.000318	0.000785	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AKR1B10—nicotine dependence	0.000317	0.000783	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—WASF2—nicotine dependence	0.000311	0.000769	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—WASF1—nicotine dependence	0.000309	0.000763	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—WASF2—nicotine dependence	0.000304	0.000752	CbGpPWpGaD
Regorafenib—ABL1—Immune System—WASF2—nicotine dependence	0.000303	0.000749	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—WASF1—nicotine dependence	0.000298	0.000737	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—WASF1—nicotine dependence	0.000292	0.000721	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.000291	0.000719	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.000291	0.000719	CbGpPWpGaD
Regorafenib—ABL1—Immune System—WASF1—nicotine dependence	0.000291	0.000718	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FGD1—nicotine dependence	0.000288	0.000712	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AKR1B10—nicotine dependence	0.000285	0.000706	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—DRD2—nicotine dependence	0.000285	0.000705	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000285	0.000704	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—OPRM1—nicotine dependence	0.000278	0.000687	CbGpPWpGaD
Regorafenib—RAF1—Immune System—WASF2—nicotine dependence	0.000277	0.000685	CbGpPWpGaD
Regorafenib—RAF1—Immune System—WASF1—nicotine dependence	0.000266	0.000657	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—OPRM1—nicotine dependence	0.000263	0.000649	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—OPRM1—nicotine dependence	0.000262	0.000647	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—WASF2—nicotine dependence	0.000262	0.000647	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—WASF2—nicotine dependence	0.000259	0.00064	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AKR1B10—nicotine dependence	0.000254	0.000629	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—WASF1—nicotine dependence	0.000251	0.00062	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—WASF1—nicotine dependence	0.000248	0.000614	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000247	0.00061	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—WASF2—nicotine dependence	0.00024	0.000594	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—WASF2—nicotine dependence	0.000236	0.000583	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—WASF1—nicotine dependence	0.00023	0.000569	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—WASF1—nicotine dependence	0.000226	0.000559	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—OPRM1—nicotine dependence	0.000226	0.000558	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—WASF2—nicotine dependence	0.000224	0.000553	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—OPRM1—nicotine dependence	0.000224	0.000553	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—WASF2—nicotine dependence	0.000223	0.000552	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—WASF1—nicotine dependence	0.000215	0.00053	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—WASF1—nicotine dependence	0.000214	0.000529	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—OPRM1—nicotine dependence	0.000207	0.000512	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—OPRM1—nicotine dependence	0.000204	0.000503	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—WASF2—nicotine dependence	0.000201	0.000497	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—DRD2—nicotine dependence	0.000201	0.000497	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—OPRM1—nicotine dependence	0.000193	0.000478	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—WASF1—nicotine dependence	0.000193	0.000477	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—OPRM1—nicotine dependence	0.000193	0.000476	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—DRD2—nicotine dependence	0.00019	0.000469	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—DRD2—nicotine dependence	0.000189	0.000468	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000181	0.000447	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—WASF2—nicotine dependence	0.000179	0.000443	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—OPRM1—nicotine dependence	0.000174	0.000429	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—WASF1—nicotine dependence	0.000172	0.000425	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DRD2—nicotine dependence	0.000163	0.000403	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DRD2—nicotine dependence	0.000162	0.0004	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—OPRM1—nicotine dependence	0.000155	0.000382	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000153	0.000378	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DRD2—nicotine dependence	0.00015	0.00037	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DRD2—nicotine dependence	0.000147	0.000364	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD2—nicotine dependence	0.00014	0.000345	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD2—nicotine dependence	0.000139	0.000344	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000137	0.000338	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000133	0.00033	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD2—nicotine dependence	0.000126	0.00031	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000125	0.000308	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD2—nicotine dependence	0.000112	0.000277	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP2A7—nicotine dependence	8.22e-05	0.000203	CbGpPWpGaD
